TENEDINI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 11.124
EU - Europa 5.559
AS - Asia 4.848
SA - Sud America 670
AF - Africa 120
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 12
Totale 22.379
Nazione #
US - Stati Uniti d'America 10.985
GB - Regno Unito 1.800
CN - Cina 1.423
SG - Singapore 1.419
IT - Italia 1.078
HK - Hong Kong 655
SE - Svezia 601
BR - Brasile 520
DE - Germania 488
VN - Vietnam 322
RU - Federazione Russa 295
FR - Francia 259
FI - Finlandia 239
TR - Turchia 234
UA - Ucraina 184
KR - Corea 146
IN - India 129
ID - Indonesia 117
IE - Irlanda 98
CA - Canada 96
BG - Bulgaria 83
NL - Olanda 66
PL - Polonia 63
IR - Iran 62
JP - Giappone 62
SI - Slovenia 59
AR - Argentina 47
ZA - Sudafrica 47
BE - Belgio 46
ES - Italia 46
AU - Australia 43
PK - Pakistan 43
IQ - Iraq 38
BD - Bangladesh 32
EC - Ecuador 31
MX - Messico 30
LT - Lituania 25
CO - Colombia 23
TW - Taiwan 21
CL - Cile 20
CZ - Repubblica Ceca 20
QA - Qatar 19
AT - Austria 18
AE - Emirati Arabi Uniti 17
MY - Malesia 17
EG - Egitto 16
MA - Marocco 16
NO - Norvegia 15
RO - Romania 15
IL - Israele 14
CH - Svizzera 12
TH - Thailandia 11
KE - Kenya 10
UZ - Uzbekistan 10
PT - Portogallo 9
VE - Venezuela 9
PE - Perù 8
TN - Tunisia 8
HU - Ungheria 7
MD - Moldavia 7
MO - Macao, regione amministrativa speciale della Cina 7
SA - Arabia Saudita 7
EU - Europa 6
KG - Kirghizistan 6
AZ - Azerbaigian 5
GR - Grecia 5
NP - Nepal 5
PH - Filippine 5
BO - Bolivia 4
GH - Ghana 4
IS - Islanda 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CI - Costa d'Avorio 3
DK - Danimarca 3
DZ - Algeria 3
GE - Georgia 3
JM - Giamaica 3
KZ - Kazakistan 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PY - Paraguay 3
SN - Senegal 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
BJ - Benin 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GY - Guiana 2
HR - Croazia 2
KW - Kuwait 2
LB - Libano 2
NG - Nigeria 2
OM - Oman 2
RS - Serbia 2
Totale 22.364
Città #
Southend 1.303
Fairfield 1.066
Santa Clara 1.015
Ashburn 982
Singapore 881
Chandler 670
Woodbridge 656
Hong Kong 622
Houston 480
Seattle 390
Ann Arbor 384
Hefei 384
Wilmington 338
Nyköping 322
Cambridge 319
Dearborn 298
Jacksonville 297
Beijing 263
London 249
Chicago 237
Modena 234
San Jose 234
Los Angeles 201
Council Bluffs 156
New York 151
Helsinki 140
Seoul 118
Izmir 106
The Dalles 101
Munich 97
Dublin 94
Ho Chi Minh City 94
Jakarta 94
Salt Lake City 94
San Diego 87
Sofia 82
Princeton 79
Moscow 72
Eugene 68
Shanghai 68
Hanoi 67
Milan 65
Tampa 62
Fremont 58
Elk Grove Village 57
Buffalo 56
Bologna 55
Dallas 55
Dong Ket 55
Frankfurt am Main 54
Redwood City 54
São Paulo 48
Bremen 45
Falls Church 44
Des Moines 40
Brussels 38
Turku 38
Warsaw 36
Guangzhou 30
Orem 30
Rome 30
Tokyo 30
Montreal 28
Boardman 27
Lancaster 27
Columbus 25
Johannesburg 25
Phoenix 23
Sterling 23
Toronto 23
Atlanta 21
Parma 21
Denver 20
Florence 20
Lauterbourg 20
Istanbul 19
Stockholm 18
Doha 17
Kent 17
Las Vegas 17
Melbourne 17
Miami 17
Nuremberg 17
Ottawa 17
Rio de Janeiro 17
Paris 16
Reggio Emilia 16
San Mateo 16
Barcelona 15
Brasília 15
Detroit 15
Quito 15
Ankara 14
Brooklyn 14
Falkenstein 14
Islamabad 14
Baghdad 13
Imola 13
Kraków 13
Poplar 13
Totale 15.265
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 506
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 467
A Next Generation Sequencing amplicon-based strategy to explore Inherited Retinal Degeneration complexity 462
Embryonic stem-derived versus somatic neural stem cells: A comparative analysis of their developmental potential and molecular phenotype 425
New modulated genes in psoriasis-derived keratinocyte subpopulations. 417
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 413
The barley Frost resistance-H2 locus 410
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 401
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 394
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells 374
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 358
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 345
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 341
ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences. 335
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 332
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Hybrid Posters 330
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 329
ANALISYS OF GENE EXPRESSION PROFILE DURING MYOGENESIS EVIDENCES DIFFERENT MOLECULAR DEFECTS AT THE BASIS OF FSHD-1 AND FSHD-2 PATHOGENESIS 328
No Identical ‘‘Mesenchymal Stem Cells’’ at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels 322
Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells 320
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 319
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 317
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 314
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 312
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 309
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 302
Tfe3 expression is closely associated to macrophage terminal differentiation of human hematopoietic myeloid precursors. 297
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 294
Hereditary pancreatic cancer: A retrospective single-center study of 5143 Italian families with history of BRCA-related malignancies 289
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 288
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 288
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 285
Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: focus on DNA repair genes 280
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 280
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 268
HGM 2010 Programme / Abstract 268
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 266
Identification of new p63 targets in human keratinocytes 259
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 259
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells 258
Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy 258
DIAGNOSI MOLECOLARE DELLE IPERTRIGLICERIDEMIE PRIMITIVE ATTRAVERSO “NGS” (NEXT GENERATION SEQUENCING) 253
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-miR-299-5p in CD34+ progenitor cells commitment 252
Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns 250
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 247
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 246
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 238
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 226
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING MULTI-GENE PANEL 223
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 220
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 219
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 219
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 217
CXCR3 identifies human naive CD8+ T cells with enhanced effector differentiation potential 217
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 216
Abnormal expression of WT1-as, MEG3 and ANRIL long non-coding RNAs in primary myelofibrosis and their clinical correlates 211
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation 210
MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response 210
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 209
Osteocytes signaling events induced by intermittent vs continuous Teriparatide treatment affect in vitro osteoblast differentiation and mineralization 209
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING (NGS) MULTI-GENE PANEL 209
Wisp2 overexpression induced by short Teriparatide treatment affects IDG-SW3 osteogenic differentiation. 204
Survival features of EBV-stabilized cells from centenarians: morpho-functional and transcriptomic analyses. 198
Workload measurement for molecular genetics laboratory: A survey study 197
Characterization of new ATM deletion associated with hereditary breast cancer 193
The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta 189
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 186
Liver Aging in Transplantation: Future Perspective on Donor-Recipient Age-Mismatch 185
Clinical application of NGS in the diagnosis of iron overload disorders or hyperferritinemia of genetic origin 183
Physiological levels of 1 alpha, 25 di-hydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors 183
Gene expression Profile of Human Myeloid Cells 178
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 178
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 175
Gene Expression profile of Vitamin D3 treated HL60 cells shows a phenotypic but not a complete functional conversion to monocytes 175
P2X7 receptor activity limits accumulation of T cells within tumors 170
Ivar, an interpretation‐oriented tool to manage the update and revision of variant annotation and classification 168
Requirement of the coiled coil domains of p92c-Fes for nuclear translocation in myeloid cells upon induction of differentiation 158
Constitutional Mosaicism: A Critical Issue in the Definition of BRCA-Inherited Cancer Risk 149
Management of PALB2-associated breast cancer: A literature review and case report 143
Pre-existing cytopenia heralding de novo acute myeloid leukemia: Uncommon presentation of NPM1-mutated AML in a single-center study 135
Targeting exhausted cytotoxic T cells through CTLA‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts 129
Clinically relevant low-frequency Next Generation Sequencing variants in hereditary cancer patients: an operational multi-step algorithm for laboratory managing 127
LOW-FREQUENCY ALLELE VARIANTS IN NGS MULTI-GENE PANELS FOR HEREDITARY CANCER TESTING: ARTIFACTS, CHIP OR MOSAICS? MANAGING THE RESULTS IN THE LABORATORY ROUTINE 127
Automation of a capture-based NGS workflow: one thousand patients experience in a diagnostic clinical routine framework 122
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-mir- 299-5p in CD34+ progenitor cells commitment 122
Detection of germline variants in 450 breast/ovarian cancer families with a multi‐gene panel including coding and regulatory regions 118
Homologous recombination deficiency in pancreatic neuroendocrine tumors 104
Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndrome 95
The prognostic and predictive role of somatic brca mutations in ovarian cancer: Results from a multicenter cohort study 94
Diagnostic Yield and Clinical Impact of a Small Genetic Panel for Kidney Disease: A Multicenter, Retrospective European Study 43
Characterization of copy number variants in hereditary cancer patients through NGS shows a distinctive PALB2 contribution to the diagnostic yield 32
Totale 22.580
Categoria #
all - tutte 83.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.853


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.204 0 0 0 0 0 0 169 228 136 268 170 233
2021/20221.859 120 192 197 102 80 135 107 75 166 179 302 204
2022/20232.167 252 261 233 213 195 269 43 198 299 18 105 81
2023/20241.505 45 82 105 132 214 142 230 190 32 49 99 185
2024/20254.750 159 72 117 264 882 699 365 327 450 259 556 600
2025/20265.078 606 363 603 955 1.556 613 382 0 0 0 0 0
Totale 22.580